FDA Approved: SYMTUZA — Supplemental Application (Janssen Products LP)

View source ↗

Summary

The FDA approved a supplemental application for SYMTUZA (darunavir/cobicistat/emtricitabine/tenofovir alafenamide) submitted by Janssen Products LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide)

Snippet

SUPPL AP for SYMTUZA (DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE)